IBDEI17Q ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21702,1,5,0)
 ;;=5^Cellulitis Of Neck
 ;;^UTILITY(U,$J,358.3,21702,2)
 ;;=^271889
 ;;^UTILITY(U,$J,358.3,21703,0)
 ;;=376.01^^133^1318^9
 ;;^UTILITY(U,$J,358.3,21703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21703,1,4,0)
 ;;=4^376.01
 ;;^UTILITY(U,$J,358.3,21703,1,5,0)
 ;;=5^Cellulitis Of Orbit
 ;;^UTILITY(U,$J,358.3,21703,2)
 ;;=^259068
 ;;^UTILITY(U,$J,358.3,21704,0)
 ;;=681.10^^133^1318^10
 ;;^UTILITY(U,$J,358.3,21704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21704,1,4,0)
 ;;=4^681.10
 ;;^UTILITY(U,$J,358.3,21704,1,5,0)
 ;;=5^Cellulitis Of Toe NOS
 ;;^UTILITY(U,$J,358.3,21704,2)
 ;;=^271885
 ;;^UTILITY(U,$J,358.3,21705,0)
 ;;=682.2^^133^1318^11
 ;;^UTILITY(U,$J,358.3,21705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21705,1,4,0)
 ;;=4^682.2
 ;;^UTILITY(U,$J,358.3,21705,1,5,0)
 ;;=5^Cellulitis Of Trunk
 ;;^UTILITY(U,$J,358.3,21705,2)
 ;;=^271890
 ;;^UTILITY(U,$J,358.3,21706,0)
 ;;=070.1^^133^1318^25
 ;;^UTILITY(U,$J,358.3,21706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21706,1,4,0)
 ;;=4^070.1
 ;;^UTILITY(U,$J,358.3,21706,1,5,0)
 ;;=5^Hepatitis A 
 ;;^UTILITY(U,$J,358.3,21706,2)
 ;;=^126486
 ;;^UTILITY(U,$J,358.3,21707,0)
 ;;=070.30^^133^1318^28
 ;;^UTILITY(U,$J,358.3,21707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21707,1,4,0)
 ;;=4^070.30
 ;;^UTILITY(U,$J,358.3,21707,1,5,0)
 ;;=5^Hepatitis B, Acute
 ;;^UTILITY(U,$J,358.3,21707,2)
 ;;=^266626
 ;;^UTILITY(U,$J,358.3,21708,0)
 ;;=070.32^^133^1318^29
 ;;^UTILITY(U,$J,358.3,21708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21708,1,4,0)
 ;;=4^070.32
 ;;^UTILITY(U,$J,358.3,21708,1,5,0)
 ;;=5^Hepatitis B, Chronic
 ;;^UTILITY(U,$J,358.3,21708,2)
 ;;=^303249
 ;;^UTILITY(U,$J,358.3,21709,0)
 ;;=070.51^^133^1318^31
 ;;^UTILITY(U,$J,358.3,21709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21709,1,4,0)
 ;;=4^070.51
 ;;^UTILITY(U,$J,358.3,21709,1,5,0)
 ;;=5^Hepatitis C, Acute
 ;;^UTILITY(U,$J,358.3,21709,2)
 ;;=^266632
 ;;^UTILITY(U,$J,358.3,21710,0)
 ;;=070.54^^133^1318^32
 ;;^UTILITY(U,$J,358.3,21710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21710,1,4,0)
 ;;=4^070.54
 ;;^UTILITY(U,$J,358.3,21710,1,5,0)
 ;;=5^Hepatitis C, Chronic
 ;;^UTILITY(U,$J,358.3,21710,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,21711,0)
 ;;=571.41^^133^1318^34
 ;;^UTILITY(U,$J,358.3,21711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21711,1,4,0)
 ;;=4^571.41
 ;;^UTILITY(U,$J,358.3,21711,1,5,0)
 ;;=5^Hepatitis, Chronic Persist
 ;;^UTILITY(U,$J,358.3,21711,2)
 ;;=^259093
 ;;^UTILITY(U,$J,358.3,21712,0)
 ;;=571.1^^133^1318^35
 ;;^UTILITY(U,$J,358.3,21712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21712,1,4,0)
 ;;=4^571.1
 ;;^UTILITY(U,$J,358.3,21712,1,5,0)
 ;;=5^Hepatitis, Etoh Acute
 ;;^UTILITY(U,$J,358.3,21712,2)
 ;;=^2597
 ;;^UTILITY(U,$J,358.3,21713,0)
 ;;=070.59^^133^1318^36
 ;;^UTILITY(U,$J,358.3,21713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21713,1,4,0)
 ;;=4^070.59
 ;;^UTILITY(U,$J,358.3,21713,1,5,0)
 ;;=5^Hepatitis, Other Viral
 ;;^UTILITY(U,$J,358.3,21713,2)
 ;;=Hepatitis, Other Viral^266631
 ;;^UTILITY(U,$J,358.3,21714,0)
 ;;=V08.^^133^1318^23
 ;;^UTILITY(U,$J,358.3,21714,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21714,1,4,0)
 ;;=4^V08.
 ;;^UTILITY(U,$J,358.3,21714,1,5,0)
 ;;=5^HIV + Status (Asymptomatic)
 ;;^UTILITY(U,$J,358.3,21714,2)
 ;;=HIV + Status (Asymptomatic)^303392
 ;;^UTILITY(U,$J,358.3,21715,0)
 ;;=042.^^133^1318^24
 ;;^UTILITY(U,$J,358.3,21715,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,21715,1,4,0)
 ;;=4^042.
 ;;^UTILITY(U,$J,358.3,21715,1,5,0)
 ;;=5^HIV Disease (Symptomatic)
 ;;^UTILITY(U,$J,358.3,21715,2)
 ;;=HIV Disease (symptomatic)^266500
